Transgene competitorsClear all

Transgene's top competitors include EpiVax, Magenta Therapeutics and Synthace.
Transgene
Transgene
Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases.
EpiVax
EpiVax
EpiVax has developed comprehensive analytical capabilities in the field of computational immunology.
Magenta Therapeutics
Magenta Therapeutics
Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.
Synthace
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
Founding Date
Founding Date
N/A
Founding Date
1998
Founding Date
2016
Founding Date
2011
Type
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Illkirch, FR HQ
Shanghai, CN
Lyon, FR
Boston, US
Locations
Providence, US HQ
Locations
Cambridge, US HQ
Locations
London, GB HQ
Cambridge, US
Employees
Employees
136
Employees
32
Employees
72
Employees
781% increase
Twitter followers
Twitter followers
1.4 k
Twitter followers
379
Twitter followers
2 k
Twitter followers
1.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
30
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.3
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
7.7
Average likes per tweet (last 30 days)
2.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
76.67%
Alexa Website Rank
Alexa Website Rank
221574
Alexa Website Rank
361738
Alexa Website Rank
429432
Alexa Website Rank
523161
Employee Rating
Employee Rating
4.4
Employee Rating
3.9
Employee Rating
N/A
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£581 (FY, 2013)
Net income
Net income
N/A
Net income
N/A
Net income
($76.8m) (FY, 2019)
Net income
(£361.6k) (FY, 2013)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 55k (about 8 years ago)
Latest funding round
N/A
Latest funding round
$ 25.6m (almost 2 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 3.2m
Total funding raised
$ 150.5m
Total funding raised
$ 41.8m
For sources of this data, please see the company profile

View company profiles

EpiVax
HQ
Providence, US
Employees
32

EpiVax has developed comprehensive analytical capabilities in the field of computational immunology.

View company
Magenta Therapeutics
HQ
Cambridge, US
Employees
72

Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.

View company
Synthace
HQ
London, GB
Employees
78↑ 1% increase

Synthace produces bio-based chemical products through the application of synthetic biology.

View company